Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  allogeneic acute myeloid leukemia antigen-expressing dendritic cell vaccine
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Vaccine Therapy with or without Durvalumab in Treating Patients with Acute Myeloid Leukemia Following Chemotherapy-Induced Remission
Status: Active
Phase: Phase II
Type: Treatment
Age: 55 and over
Trial IDs: 16-593, NCI-2017-01191, NCT03059485
Start Over